Sahajanand Medical Technologies sets IPO price band at Rs 327-344 per share; issue opens on Oct 15

Sahajanand Medical Technologies Limited has fixed a price band of Rs 327-344 per equity share for its initial public offering (IPO), set to open for subscription on Thursday, October 15, 2026.

The medical devices maker aims to raise Rs 475.48 crore through the public issue, which comprises an offer for sale (OFS) of up to 1,38,22,116 equity shares with a face value of Re 1 each. The selling shareholders include the promoter, Shree Hari Trust; promoter group member Dhirajkumar Savjibhai Vasoya; and investors Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B.V.

Since the IPO is entirely an offer for sale, the company will not receive any proceeds from the issue. The proceeds will go to the selling shareholders.

Investors can bid for a minimum of 43 equity shares and in multiples of 43 shares thereafter.

The offer is being made through the book-building process. The company has said that not more than 50% of the net offer will be reserved for qualified institutional buyers (QIBs), while at least 15% will be allocated to non-institutional investors (NIIs) and at least 35% to retail individual investors.

The three-day subscription window is scheduled to close on Monday, October 19, 2026. The basis of allotment is tentatively expected to be finalised on Tuesday, October 20, while the equity shares are scheduled to list on the BSE and NSE on Thursday, October 22, 2026.

ALSO READ: Cheap Venezuelan crude could add up to Rs 12,600 crore to RIL’s EBITDA. What investors should know

Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management are the book-running lead managers to the issue. MUFG Intime India is the registrar.

About Sahajanand Medical Technologies

Sahajanand Medical Technologies is a medical devices company focused on vascular and structural heart interventions. Its portfolio comprises Class III and Class C/D medical devices, including products used in cardiovascular procedures.

Sahajanand Medical Technologies reported a 174.6% year-on-year jump in profit after tax to Rs 69.082 crore in FY26, compared with Rs 25.152 crore in the previous fiscal. Revenue from operations rose 18.1% to Rs 1,210.504 crore in FY26 from Rs 1,024.879 crore in FY25. For the three months ended June 30, 2026, the company reported a profit after tax of Rs 15.087 crore and revenue from operations of Rs 351.669 crore.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Add as a Reliable and Trusted News Source Add Now!
(You can now subscribe to our ETMarkets WhatsApp channel)